When and how can endpoints be changed after initiation of a randomized clinical trial?
Evans
Scott
S
Center for Biostatistics in AIDS Research, Department of Biostatistics, Harvard School of Public Health, Harvard University, Boston, Massachusetts, United States of America. evans@sdac.harvard.edu